Literature DB >> 23664514

Standardized clinical assessment and management plans (SCAMPs): perspectives on a new method to understand treatment decisions and outcomes in immune thrombocytopenia.

Rachael F Grace1.   

Abstract

Modern evidence based guidelines in immune thrombocytopenia (ITP) are mostly based on expert opinion. Standardized clinical assessment and management plans (SCAMPs) are flexible, feedback-based practice guidelines that could be valuable for both managing patients with ITP and understanding treatment decisions and outcomes. At Boston Children's Hospital, we have implemented a SCAMP for patients with newly diagnosed and persistent ITP. To develop the algorithm, a group of local ITP experts devised an initial guideline, which was then modified by the attending hematologists who care for ITP patients until consensus was reached. Since deviations from the algorithm are encouraged, all clinicians did not need to agree with all aspects of the algorithm. At each clinic visit, clinicians fill out data collection forms explaining practice deviations. The goals of this process are to decrease practice variation and resource utilization and learn from the outcomes and deviations that occur to continually improve our practice. SCAMPs are an innovative approach to improve quality of care in ITP.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23664514      PMCID: PMC3767410          DOI: 10.1053/j.seminhematol.2013.03.017

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  35 in total

1.  Dynamic evolution of practice guidelines: analysis of deviations from assessment and management plans.

Authors:  Michael Farias; Kevin G Friedman; Andrew J Powell; Sarah D de Ferranti; Audrey C Marshall; David W Brown; Thomas J Kulik
Journal:  Pediatrics       Date:  2012-06-04       Impact factor: 7.124

Review 2.  The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.

Authors:  Cindy Neunert; Wendy Lim; Mark Crowther; Alan Cohen; Lawrence Solberg; Mark A Crowther
Journal:  Blood       Date:  2011-02-16       Impact factor: 22.113

3.  How Intermountain trimmed health care costs through robust quality improvement efforts.

Authors:  Brent C James; Lucy A Savitz
Journal:  Health Aff (Millwood)       Date:  2011-05-19       Impact factor: 6.301

4.  Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia.

Authors:  Patrick F Fogarty; Michael D Tarantino; Andres Brainsky; James Signorovitch; Kelly M Grotzinger
Journal:  Curr Med Res Opin       Date:  2011-12-20       Impact factor: 2.580

Review 5.  Childhood immune thrombocytopenia: a changing therapeutic landscape.

Authors:  Vicky R Breakey; Victor S Blanchette
Journal:  Semin Thromb Hemost       Date:  2011-12-20       Impact factor: 4.180

6.  Prevalence of autoantibodies related to some autoimmune disorders in patients with chronic idiopathic thrombocytopenic purpura.

Authors:  Cengiz Demir; Ramazan Esen; Murat Atmaca; Servet Efe
Journal:  Clin Appl Thromb Hemost       Date:  2010-12-15       Impact factor: 2.389

7.  Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults.

Authors:  M Colović; N Suvajdzic; N Colović; D Tomin; A Vidović; V Palibrk
Journal:  Platelets       Date:  2010-12-08       Impact factor: 3.862

Review 8.  Approach to the investigation and management of immune thrombocytopenic purpura in children.

Authors:  V Blanchette; M Carcao
Journal:  Semin Hematol       Date:  2000-07       Impact factor: 3.851

9.  Provider attitudes toward Standardized Clinical Assessment and Management Plans (SCAMPs).

Authors:  Michael Farias; Sonja Ziniel; Rahul H Rathod; Kevin G Friedman; Steven Colan; Jane W Newburger; David R Fulton
Journal:  Congenit Heart Dis       Date:  2011-10-17       Impact factor: 2.007

10.  Quality of life in childhood immune thrombocytopenia: international validation of the kids' ITP tools.

Authors:  Robert J Klaassen; Victor Blanchette; Tricia A Burke; Cindy Wakefield; John D Grainger; Gerhard Gaedicke; Arne Riedlinger; Gustavo Dufort; Estela Citrin; Yves Reguerre; Isabelle Pellier; Christine Curtis; Nancy L Young
Journal:  Pediatr Blood Cancer       Date:  2012-07-27       Impact factor: 3.167

View more
  2 in total

Review 1.  SCAMPs for Multimodal Post-Operative Analgesia: A Concept to Standardize and Individualize Care.

Authors:  Anair Beverly; Alan D Kaye; Richard D Urman
Journal:  Curr Pain Headache Rep       Date:  2017-01

2.  Increasing observation rates in low-risk pediatric immune thrombocytopenia using a standardized clinical assessment and management plan (SCAMP® ).

Authors:  Michelle L Schoettler; Dionne Graham; Wen Tao; Margaret Stack; Elaine Shu; Lauren Kerr; Ellis J Neufeld; Rachael F Grace
Journal:  Pediatr Blood Cancer       Date:  2016-10-26       Impact factor: 3.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.